163 related articles for article (PubMed ID: 28862484)
21. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcomes after high dose therapy and autologous haematopoietic cell rescue for refractory/relapsed Hodgkin lymphoma.
Minn AY; Riedel E; Halpern J; Johnston LJ; Horning SJ; Hoppe RT; Goodman KA
Br J Haematol; 2012 Nov; 159(3):329-39. PubMed ID: 22966754
[TBL] [Abstract][Full Text] [Related]
23. Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan.
Oeffinger KC; Hudson MM; Mertens AC; Smith SM; Mitby PA; Eshelman-Kent DA; Ford JS; Jones JK; Kamani S; Robison LL
Pediatr Blood Cancer; 2011 May; 56(5):818-24. PubMed ID: 21370417
[TBL] [Abstract][Full Text] [Related]
24. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence.
Acharya S; Sarafoglou K; LaQuaglia M; Lindsley S; Gerald W; Wollner N; Tan C; Sklar C
Cancer; 2003 May; 97(10):2397-403. PubMed ID: 12733137
[TBL] [Abstract][Full Text] [Related]
25. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
Gerber NK; Atoria CL; Elkin EB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
[TBL] [Abstract][Full Text] [Related]
26. Risk of second malignancies among survivors of pediatric thyroid cancer.
Adly MH; Sobhy M; Rezk MA; Ishak M; Afifi MA; Shafie AE; Ali MA; Zekri W; Alfaar AS; Rashed WM
Int J Clin Oncol; 2018 Aug; 23(4):625-633. PubMed ID: 29492793
[TBL] [Abstract][Full Text] [Related]
27. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.
Castellino SM; Geiger AM; Mertens AC; Leisenring WM; Tooze JA; Goodman P; Stovall M; Robison LL; Hudson MM
Blood; 2011 Feb; 117(6):1806-16. PubMed ID: 21037086
[TBL] [Abstract][Full Text] [Related]
28. Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
van Eggermond AM; Schaapveld M; Janus CP; de Boer JP; Krol AD; Zijlstra JM; van der Maazen RW; Kremer LC; van Leerdam ME; Louwman MW; Visser O; De Bruin ML; Aleman BM; van Leeuwen FE
Br J Cancer; 2017 Jul; 117(3):306-314. PubMed ID: 28632726
[TBL] [Abstract][Full Text] [Related]
29. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
Xavier AC; Armeson KE; Hill EG; Costa LJ
Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
[TBL] [Abstract][Full Text] [Related]
30. Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study.
Milano MT; Li H; Gail MH; Constine LS; Travis LB
J Clin Oncol; 2010 Dec; 28(34):5088-96. PubMed ID: 20975072
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant chemotherapy administration and survival outcomes of lymphoma survivors with common solid tumors: a population-based study†.
Di M; Panagiotou OA; Reagan JL; Niroula R; Olszewski AJ
Leuk Lymphoma; 2020 Dec; 61(14):3360-3368. PubMed ID: 32915087
[TBL] [Abstract][Full Text] [Related]
32. Hodgkin lymphoma in Tyrol-a population-based study.
Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A
Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373
[TBL] [Abstract][Full Text] [Related]
33. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.
Hodgson DC; Gilbert ES; Dores GM; Schonfeld SJ; Lynch CF; Storm H; Hall P; Langmark F; Pukkala E; Andersson M; Kaijser M; Joensuu H; Fosså SD; Travis LB
J Clin Oncol; 2007 Apr; 25(12):1489-97. PubMed ID: 17372278
[TBL] [Abstract][Full Text] [Related]
34. Radiation treatment of patients with primary pediatric malignancies: risk of developing thyroid cancer as a secondary malignancy.
Rose J; Wertheim BC; Guerrero MA
Am J Surg; 2012 Dec; 204(6):881-6; discussion 886-7. PubMed ID: 23026382
[TBL] [Abstract][Full Text] [Related]
35. Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
Conway JL; Connors JM; Tyldesley S; Savage KJ; Campbell BA; Zheng YY; Hamm J; Pickles T
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):35-41. PubMed ID: 27979454
[TBL] [Abstract][Full Text] [Related]
36. Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era.
LeMieux MH; Solanki AA; Mahmood U; Chmura SJ; Koshy M
Cancer Med; 2015 Apr; 4(4):513-8. PubMed ID: 25620577
[TBL] [Abstract][Full Text] [Related]
37. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.
Wattson DA; Hunink MG; DiPiro PJ; Das P; Hodgson DC; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):344-53. PubMed ID: 25104066
[TBL] [Abstract][Full Text] [Related]
38. Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study.
Glimelius I; Ekberg S; Linderoth J; Jerkeman M; Chang ET; Neovius M; Smedby KE
J Cancer Surviv; 2015 Dec; 9(4):599-609. PubMed ID: 25689964
[TBL] [Abstract][Full Text] [Related]
39. Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphoma.
Wang L; Zheng Y; Luo R; Kang K; Niedermann G; Zhao A; Wu Y
J Cancer Res Clin Oncol; 2024 Jan; 150(2):41. PubMed ID: 38280006
[TBL] [Abstract][Full Text] [Related]
40. Primary lymph node sites in Hodgkin lymphoma and the risk of second primary cancers: a population-based study.
Ebied A; Yousif M; Nam NH; Elhamamsy AR; Hassan OG; Mostafa EM; Nguyen GJ; Hirayama K; Huy NT
Future Oncol; 2020 Mar; 16(9):451-467. PubMed ID: 32096658
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
